MILWAUKEE, March 13, 2024 – ConsortiEX, an industry leader in compliance and patient-safety focused software and services for outsourcing and hospital pharmacies, is pleased to announce a new strategic partnership with LedgerDomain, a pioneering identity and secure messaging platform tailored for modern decentralized healthcare. This collaboration marks a significant step forward in enhancing the safety and efficacy of prescription drugs across the U.S. pharmaceutical supply chain.
By November 27, 2024, the U.S. pharmaceutical supply chain must exchange product compliance information, including drug verification and tracing data, in a fully interoperable manner. To ensure seamless authentication and prevent bad actors from accessing sensitive information, LedgerDomain and ConsortiEX are providing a joint approach for trading partners based on specifications developed in close collaboration with industry stakeholders, including the Partnership for DSCSA Governance (PDG) the Healthcare Distribution Alliance (HDA) VRS Working Group, GS1 US, and the Open Credentialing Initiative (OCI). Read More >
ConsortiEX serves the pharmacy community by offering DSCSA (Drug Supply Chain Security Act) compliance and IV Workflow Management solutions. Our services are designed to overcome the challenges of Drug Quality and Security Act (DQSA) compliance, allowing providers to focus entirely on serving their patients, and their communities.
This post is related to:
Compounding: IV/Infusion Resources/USP <797> Resources Compounding: USP <800> Compliance Distribution: DSCSA Solutions Practice Setting: Health System Pharmacy Resources Practice Setting: Infusion Pharmacy Resources Software: Drug Diversion Monitoring, Diversion Prevention Software: IV Workflow Management
